Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beken Bio is a biotechnology company focused on revolutionizing early cancer detection through minimally invasive liquid biopsies. The company's proprietary 3D REVEAL™ engine leverages a unique 3D cell growth platform and machine learning AI to identify novel cancer biomarkers within extracellular vesicles (EVs) before clinical symptoms manifest. By isolating and analyzing the molecular signatures of cancer-specific EVs, Beken Bio develops diagnostic tests for high-mortality cancers, including ovarian, pancreatic, and lung cancer. Recently relocated to New Orleans, the company is advancing its lead ovarian cancer screening test toward clinical commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beken Bio.